Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459687
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-03
Brief Title:
Phase III Study of Socazolimab as First-Line Treatment in Persistent Recurrent or Metastatic Cervical Cancer
Sponsor:
Organization:
Lees Pharmaceutical Limited